中国药物评价
中國藥物評價
중국약물평개
Chinese Journal of Drug Evaluation
2015年
4期
215-219
,共5页
夏旭东%张雨%王丽%杨雪%任彦润
夏旭東%張雨%王麗%楊雪%任彥潤
하욱동%장우%왕려%양설%임언윤
注射用七叶皂苷钠%不良反应/事件%分析
註射用七葉皂苷鈉%不良反應/事件%分析
주사용칠협조감납%불량반응/사건%분석
Aescine sodium injection%Adverse drug reaction/event%Analysis
目的:分析注射用七叶皂苷钠不良反应发生的一般规律及特点,为临床合理用药提供参考。方法:采用回顾性研究方法,对某省药品不良反应监测中心ADR报告数据库中2009~2014年注射用七叶皂苷钠ADR/ADE报告进行统计和分析。结果:注射用七叶皂苷钠所致不良反应主要为用药部位损害404例次(28.55%),皮肤及其附件损害374例次(26.43%),全身性损害296例次(20.92%);ADR/ADE表现较多的有注射部位疼痛、皮疹、静脉炎等。结论:重视注射用七叶皂苷钠引发的不良反应,提高临床合理用药水平,完善药品说明书,防止严重不良反应发生,确保临床用药安全。
目的:分析註射用七葉皂苷鈉不良反應髮生的一般規律及特點,為臨床閤理用藥提供參攷。方法:採用迴顧性研究方法,對某省藥品不良反應鑑測中心ADR報告數據庫中2009~2014年註射用七葉皂苷鈉ADR/ADE報告進行統計和分析。結果:註射用七葉皂苷鈉所緻不良反應主要為用藥部位損害404例次(28.55%),皮膚及其附件損害374例次(26.43%),全身性損害296例次(20.92%);ADR/ADE錶現較多的有註射部位疼痛、皮疹、靜脈炎等。結論:重視註射用七葉皂苷鈉引髮的不良反應,提高臨床閤理用藥水平,完善藥品說明書,防止嚴重不良反應髮生,確保臨床用藥安全。
목적:분석주사용칠협조감납불량반응발생적일반규률급특점,위림상합리용약제공삼고。방법:채용회고성연구방법,대모성약품불량반응감측중심ADR보고수거고중2009~2014년주사용칠협조감납ADR/ADE보고진행통계화분석。결과:주사용칠협조감납소치불량반응주요위용약부위손해404례차(28.55%),피부급기부건손해374례차(26.43%),전신성손해296례차(20.92%);ADR/ADE표현교다적유주사부위동통、피진、정맥염등。결론:중시주사용칠협조감납인발적불량반응,제고림상합리용약수평,완선약품설명서,방지엄중불량반응발생,학보림상용약안전。
Objective:To provide references for the clinical rational use of drug by analyzing the general pattern and characteristics of adverse drug reactions caused by Aescine sodium injection .Methods:A total of 1149 ADR/ADE cases of Aescine sodium injection collect-ed by Henan center for ADR monitoring from 2009 to 2014 were analyzed by retrospective study .Results: The main adverse reactions of Aescine sodium injection were administration site disorder (404 cases, 28.55%), skin and appendages disorders (374 cases, 26.43%), whole-general body disorder (296 cases, 20.92%).The common serious reactions were showed as pain at the injection site , erythra, and phlebophlogosis, ect.Conclusion:It is important to pay attention to the ADR/ADE caused by Aescine sodium injection, in order to improve the rational use in clinical, complete the drug specification, prevent serious adverse drug reactions, and ensure clinical medication safety.